5-HT1B autoreceptor regulation of serotonin transporter activity in synaptosomes

Synapse

Volumn 66, Issue 12, 2012, Pages 1024-1034

  Hagan, Catherine E ^a   Mcdevitt, Ross A ^a,b,c   Liu, Yusha ^b   Furay, Amy R ^b   Neumaier, John F ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

1B; 5 HT; CP94253; Knockout; Overexpression; SB224289; Serotonergic; SERT; Uptake; Voltammetry

Indexed keywords

NEUROTRANSMITTER RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE DELETION; MALE; MOUSE; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNAPTOSOME;

ANIMALS; GENE DELETION; MICE; PIPERIDONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONERGIC NEURONS; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SPIRO COMPOUNDS; SYNAPTOSOMES; UP-REGULATION;

EID: 84867649082     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21608     Document Type: Article

References (64)

1. Amara SG, Sonders MS. 1998. Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend 51: 87-96.
2. Artigas F, Perez V, Alvarez E. 1994. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51: 248-251.
3. Artigas F, Celada P, Laruelle M, Adell A. 2001. How does pindolol improve antidepressant action? Trends Pharmacol Sci 22: 224-228.
4. Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic N, Jeske NA, Koek W, Toney GM, Daws LC. 2008. Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci USA 105: 18976-18981.
5. Baganz N, Horton R, Martin K, Holmes A, Daws LC. 2010. Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: Organic cation transporter 3, the smoking gun. J Neurosci 30: 15185-15195.
6. Barot SK, Ferguson SM, Neumaier JF. 2007. 5-HT(1B) receptors in nucleus accumbens efferents enhance both rewarding and aversive effects of cocaine. Eur J Neurosci 25: 3125-3131.
7. Blakely RD, De Felice LJ, Hartzell HC. 1994. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196: 263-281.
8. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ. 1998. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry 44: 169-178.
9. Bruchas MR, Schindler AG, Shankar H, Messinger DI, Miyatake M, Land BB, Lemos JC, Hagan CE, Neumaier JF, Quintana A, Palmiter RD, Chavkin C. 2011. Selective p38alpha MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron 71: 498-511.
10. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. 2003. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389.
11. Clark MS, Neumaier JF. 2001. The 5-HT1B receptor: Behavioral implications. Psychopharmacol Bull 35: 170-185.
12. Clark MS, Sexton TJ, McClain M, Root D, Kohen R, Neumaier JF. 2002. Overexpression of 5-HT1B receptor in dorsal raphe nucleus using Herpes Simplex Virus gene transfer increases anxiety behavior after inescapable stress. J Neurosci 22: 4550-4562.
13. Clark MS, Vincow ES, Sexton TJ, Neumaier JF. 2004. Increased expression of 5-HT1B receptor in dorsal raphe nucleus decreases fear-potentiated startle in a stress dependent manner. Brain Res 1007: 86-97.
14. Daws LC. 2009. Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther 121: 89-99.
15. Daws LC, Gould GG. 2011. Ontogeny and regulation of the serotonin transporter: Providing insights into human disorders. Pharmacol Ther 131: 61-79.
16. Daws LC, Toney GM. 2007. High-speed chronoamperometry to study kinetics and mechanisms for serotonin clearance in vivo. In: Michael AC, Borland LM, editors. Electrochemical methods for neuroscience. Boca Raton, FL: CRC Press. p 63-81.
17. Daws LC, Gerhardt GA, Frazer A. 1999. 5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus. Neurosci Lett 266: 165-168.
18. Daws LC, Gould GG, Teicher SD, Gerhardt GA, Frazer A. 2000. 5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. J Neurochem 75: 2113-2122.
19. Feng N, Mo B, Johnson PL, Orchinik M, Lowry CA, Renner KJ. 2005. Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res 1063: 69-76.
20. Ferguson SM, Mitchell ES, Neumaier JF. 2008. Increased expression of 5-HT6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine. Biol Psychiatry 63: 207-213.
21. Gardier AM. 2009. Mutant mouse models and antidepressant drug research: Focus on serotonin and brain-derived neurotrophic factor. Behav Pharmacol 20: 18-32.
22. Gasser PJ, Lowry CA, Orchinik M. 2006. Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: Potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 26: 8758-8766.
23. Gaster LM, Ham P, Joiner GF, King FD, Mulholland KR, Wyman PA, Hagan JJ, Price GW, Roberts C, Routledge C, Selkirk J, Slade PD, Middlemiss DN. 1998. The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. Ann N Y Acad Sci 861: 270-271.
24. Hagan CE, Neumaier JF, Schenk JO. 2010. Rotating disk electrode voltammetric measurements of serotonin transporter kinetics in synaptosomes. J Neurosci Methods 193: 29-38.
25. Hagan CE, Schenk JO, Neumaier JF. 2011. The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes. Synapse 65: 1015-1023.
26. Hjorth S, Suchowski CS, Galloway MP. 1995. Evidence for 5-HT autoreceptor-mediated, nerve impulse-independent, control of 5-HT synthesis in the rat brain. Synapse 19: 170-176.
27. Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB. 2000. Serotonin autoreceptor function and antidepressant drug action. J Psychopharmacol 14: 177-185.
28. Hoyer D, Middlemiss DN. 1989. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol Sci 10: 130-132.
29. Huang T, Kissinger PT. 1996. Liquid chromatographic determination of serotonin in homogenized dog intestine and rat brain tissue using a 2 mm i.d. PEEK Column. Curr Separat 14: 114-119.
30. Iversen L. 1971. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41: 571-591.
31. Kaiyala KJ, Vincow ES, Sexton TJ, Neumaier JF. 2003. 5-HT1B receptor mRNA levels in dorsal raphe nucleus: Inverse association with anxiety behavior in the elevated plus maze. Pharmacol Biochem Behav 75: 769-776.
32. Lawrie A, Spiekerkoetter E, Martinez EC, Ambartsumian N, Sheward WJ, MacLean MR, Harmar AJ, Schmidt AM, Lukanidin E, Rabinovitch M. 2005. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circ Res 97: 227-235.
33. Lemos JC, Pan YZ, Ma X, Lamy C, Akanwa AC, Beck SG. 2006. Selective 5-HT receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe. Eur J Neurosci 24: 3415-3430.
34. Leranth C, Vertes RP. 1999. Median raphe serotonergic innervation of medial septum/diagonal band of broca (MSDB) parvalbumin-containing neurons: Possible involvement of the MSDB in the desynchronization of the hippocampal EEG. J Comp Neurol 410: 586-598.
35. McDevitt RA, Neumaier JF. 2011. Regulation of dorsal raphe nucleus function by serotonin autoreceptors: A behavioral perspective. J Chem Neuroanat 41: 234-246.
36. McDevitt RA, Hiroi R, Mackenzie SM, Robin NC, Cohn A, Kim JJ, Neumaier JF. 2011. Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior. Biol Psychiatry 69: 780-787.
37. Morecroft I, Loughlin L, Nilsen M, Colston J, Dempsie Y, Sheward J, Harmar A, MacLean MR. 2005. Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries. J Pharmacol Exp Ther 313: 539-548.
38. Morikawa H, Manzoni OJ, Crabbe JC, Williams JT. 2000. Regulation of central synaptic transmission by 5-HT(1B) auto- and heteroreceptors. Mol Pharmacol 58: 1271-1278.
39. Neumaier JF, Edwards E, Plotsky PM. 2002. 5-HT(1B) mRNA regulation in two animal models of altered stress reactivity. Biol Psychiatry 51: 902-908.
40. Quick MW. 2003. Regulating the conducting states of a mammalian serotonin transporter. Neuron 40: 537-549.
41. Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X, el Mestikawy S, Hamon M, Descarries L. 2000. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 417: 181-194.
42. Riegert C, Rothmaier AK, Leemhuis J, Sexton TJ, Neumaier JF, Cassel JC, Jackisch R. 2008. Increased expression of 5-HT(1B) receptors by Herpes simplex virus gene transfer in septal neurons: New in vitro and in vivo models to study 5-HT(1B) receptor function. Brain Res Bull 76: 439-453.
43. Rudnick G. 2006. Serotonin transporters-Structure and function. J Membr Biol 213: 101-110.
44. Sarhan H, Cloez-Tayarani I, Massot O, Fillion MP, Fillion G. 1999. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes. Naunyn Schmiedebergs Arch Pharmacol 359: 40-47.
45. Sarhan H, Fillion G. 1999. Differential sensitivity of 5-HT1B auto and heteroreceptors. Naunyn Schmiedebergs Arch Pharmacol 360: 382-390.
46. Sari Y. 2004. Serotonin1B receptors: From protein to physiological function and behavior. Neurosci Biobehav Rev 28: 565-582.
47. Sayer TJ, Hannon SD, Redfern PH, Martin KF. 1999. Diurnal variation in 5-HT1B autoreceptor function in the anterior hypothalamus in vivo: Effect of chronic antidepressant drug treatment. Br J Pharmacol 126: 1777-1784.
48. Scearce-Levie K, Chen JP, Gardner E, Hen R. 1999. 5-HT receptor knockout mice: Pharmacological tools or models of psychiatric disorders. Ann N Y Acad Sci 868: 701-715.
49. Schmitt A, Mossner R, Gossmann A, Fischer IG, Gorboulev V, Murphy DL, Koepsell H, Lesch KP. 2003. Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res 71: 701-709.
50. Selkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, Collin L, Jones BJ, Middlemiss DN, Price GW. 1998. SB-224289-A novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Br J Pharmacol 125: 202-208.
51. Sexton TJ, McEvoy C, Neumaier JF. 1999. (+) 3, 4-methylenedioxymethamphetamine ('ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain. Mol Psychiatry 4: 572-579.
52. Shanahan NA, Holick Pierz KA, Masten VL, Waeber C, Ansorge M, Gingrich JA, Geyer MA, Hen R, Dulawa SC. 2009. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. Biol Psychiatry 65: 401-408.
53. Stamford JA, Davidson C, McLaughlin DP, Hopwood SE. 2000. Control of dorsal raphe 5-HT function by multiple 5-HT(1) autoreceptors: parallel purposes or pointless plurality? Trends Neurosci 23: 459-465.
54. Steiner JA, Carneiro AM, Blakely RD. 2008. Going with the flow: Trafficking-dependent and -independent regulation of serotonin transport. Traffic 9: 1393-1402.
55. Sulzer D, Edwards RH. 2005. Antidepressants and the monoamine masquerade. Neuron 46: 1-2.
56. Trillat AC, Malagie I, Scearce K, Pons D, Anmella MC, Jacquot C, Hen R, Gardier AM. 1997. Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: In vivo microdialysis studies. J Neurochem 69: 2019-2025.
57. Vertes RP. 1991. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 313: 643-668.
58. Vertes RP, Fortin WJ, Crane AM. 1999. Projections of the median raphe nucleus in the rat. J Comp Neurol 407: 555-582.
59. White KJ, Walline CC, Barker EL. 2005. Serotonin transporters: Implications for antidepressant drug development. AAPS J 7: E421-E433.
60. Xie Z, Westmoreland SV, Miller GM. 2008. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes. J Pharmacol Exp Ther 325: 629-640.
61. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD. 2005. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 280: 15649-15658.
62. Zhu CB, Blakely RD, Hewlett WA. 2006. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31: 2121-2131.
63. Zhu CB, Steiner JA, Munn JL, Daws LC, Hewlett WA, Blakely RD. 2007. Rapid stimulation of presynaptic serotonin transport by A3 adenosine receptors. J Pharmacol Exp Ther 322: 332-340.
64. Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA. 2010. Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35: 2510-2520.